ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2023

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 6,287,101$5,815,5692.85%
Syncona Portfolio Ltd 1,377,294$1,273,9971.92%
NEA Management Company, LLC 17,079,778$15,798,7951.21%
MPM BioImpact LLC 5,095,912$4,713,7190.95%
TANG CAPITAL MANAGEMENT LLC 4,887,238$4,520,6950.67%
Endurant Capital Management LP 821,038$759,4600.66%
Matrix Capital Management Company, LP 38,974,185$36,051,1210.42%
Long Focus Capital Management, LLC 7,812,528$7,226,5880.33%
PFM Health Sciences, LP 8,357,242$7,730,4490.30%
Key Client Fiduciary Advisors, LLC 329,155$304,4680.18%
DAFNA Capital Management LLC 351,064$324,7340.09%
Rock Springs Capital Management LP 2,787,845$2,578,7570.06%
Baker Brothers Advisors 10,969,282$10,146,5860.06%
Black Maple Capital Management LP 69,839$64,6010.04%
Artal Group S.A. 1,133,775$1,0490.03%
Diametric Capital, LP 78,441$72,5580.03%
Redmile Group, LLC 715,607$661,9360.02%
HARBOR CAPITAL ADVISORS, INC. 112,516$104,0770.02%
Prosperity Wealth Management, Inc. 30,620$28,3240.02%
Simplify Asset Management Inc. 150,000$138,7500.02%
External links

This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q2 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.